473 related articles for article (PubMed ID: 32951446)
1. Efficacy of Povidone-Iodine Nasal and Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2).
Pelletier JS; Tessema B; Frank S; Westover JB; Brown SM; Capriotti JA
Ear Nose Throat J; 2021 Apr; 100(2_suppl):192S-196S. PubMed ID: 32951446
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Efficacy of a Povidone-Iodine Nasal Antiseptic for Rapid Inactivation of SARS-CoV-2.
Frank S; Brown SM; Capriotti JA; Westover JB; Pelletier JS; Tessema B
JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):1054-1058. PubMed ID: 32940656
[TBL] [Abstract][Full Text] [Related]
3. Rapid In-Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Using Povidone-Iodine Oral Antiseptic Rinse.
Bidra AS; Pelletier JS; Westover JB; Frank S; Brown SM; Tessema B
J Prosthodont; 2020 Jul; 29(6):529-533. PubMed ID: 32511851
[TBL] [Abstract][Full Text] [Related]
4. Comparison of In Vitro Inactivation of SARS CoV-2 with Hydrogen Peroxide and Povidone-Iodine Oral Antiseptic Rinses.
Bidra AS; Pelletier JS; Westover JB; Frank S; Brown SM; Tessema B
J Prosthodont; 2020 Aug; 29(7):599-603. PubMed ID: 32608097
[TBL] [Abstract][Full Text] [Related]
5. Povidone-Iodine Use in Sinonasal and Oral Cavities: A Review of Safety in the COVID-19 Era.
Frank S; Capriotti J; Brown SM; Tessema B
Ear Nose Throat J; 2020 Nov; 99(9):586-593. PubMed ID: 32520599
[TBL] [Abstract][Full Text] [Related]
6. In vitro inactivation of SARS-CoV-2 using a povidone-iodine oral rinse.
Shet M; Westover J; Hong R; Igo D; Cataldo M; Bhaskar S
BMC Oral Health; 2022 Feb; 22(1):47. PubMed ID: 35216566
[TBL] [Abstract][Full Text] [Related]
7. Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease.
Anderson DE; Sivalingam V; Kang AEZ; Ananthanarayanan A; Arumugam H; Jenkins TM; Hadjiat Y; Eggers M
Infect Dis Ther; 2020 Sep; 9(3):669-675. PubMed ID: 32643111
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of "Essential Iodine Drops" against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2).
Köntös Z
PLoS One; 2021; 16(7):e0254341. PubMed ID: 34242340
[TBL] [Abstract][Full Text] [Related]
9. Oral antiseptics against coronavirus: in-vitro and clinical evidence.
Mateos-Moreno MV; Mira A; Ausina-Márquez V; Ferrer MD
J Hosp Infect; 2021 Jul; 113():30-43. PubMed ID: 33865974
[TBL] [Abstract][Full Text] [Related]
10. A Review of Topical Povidone-iodine to Decrease Viral Load of COViD-19.
Benson KM; Mancini AA; Brodeur MR
Sr Care Pharm; 2021 May; 36(5):238-241. PubMed ID: 33879284
[TBL] [Abstract][Full Text] [Related]
11. Considerations for povidone-iodine antisepsis in pediatric nasal and pharyngeal surgery during the COVID-19 pandemic.
Chorney SR; Rizzi MD; Dedhia K
Am J Otolaryngol; 2020; 41(6):102737. PubMed ID: 32979667
[TBL] [Abstract][Full Text] [Related]
12. In vivo evaluation of the virucidal efficacy of chlorhexidine and povidone-iodine mouthwashes against salivary SARS-CoV-2. A randomized-controlled clinical trial.
Elzein R; Abdel-Sater F; Fakhreddine S; Hanna PA; Feghali R; Hamad H; Ayoub F
J Evid Based Dent Pract; 2021 Sep; 21(3):101584. PubMed ID: 34479668
[TBL] [Abstract][Full Text] [Related]
13. Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic.
Khan MM; Parab SR; Paranjape M
Am J Otolaryngol; 2020; 41(5):102618. PubMed ID: 32574894
[TBL] [Abstract][Full Text] [Related]
14. Role of antiseptics in the prevention and treatment of infections in nursing homes.
Alves PJ; Gryson L; Hajjar J; Lepelletier D; Reners M; Rodríguez Salazar J; Simon A
J Hosp Infect; 2023 Jan; 131():58-69. PubMed ID: 36216172
[TBL] [Abstract][Full Text] [Related]
15. Effect of oral antiseptics on the viral load of SARS-CoV-2: A randomized controlled trial.
Sevinç Gül SN; Dilsiz A; Sağlık İ; Aydın NN
Dent Med Probl; 2022; 59(3):357-363. PubMed ID: 35904769
[TBL] [Abstract][Full Text] [Related]
16. Repurposing povidone-iodine to reduce the risk of SARS-CoV-2 infection and transmission: a narrative review.
Lim NA; Teng O; Ng CYH; Bao LXY; Tambyah PA; Quek AML; Seet RCS
Ann Med; 2022 Dec; 54(1):1488-1499. PubMed ID: 35594333
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Mouth Rinses and Nasal Spray in the Inactivation of SARS-CoV-2: A Systematic Review and Meta-Analysis of
Idrees M; McGowan B; Fawzy A; Abuderman AA; Balasubramaniam R; Kujan O
Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231450
[TBL] [Abstract][Full Text] [Related]
18. Virucidal effect of povidone-iodine against SARS-CoV-2
Wang Y; Wu Y; Wang Q; Zhu J; Shi W; Han Z; Zhang Y; Chen K
J Int Med Res; 2021 Dec; 49(12):3000605211063695. PubMed ID: 34914884
[TBL] [Abstract][Full Text] [Related]
19. Review of the use of nasal and oral antiseptics during a global pandemic.
Stathis C; Victoria N; Loomis K; Nguyen SA; Eggers M; Septimus E; Safdar N
Future Microbiol; 2021 Jan; 16(2):119-130. PubMed ID: 33464122
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of povidone-iodine nasal rinse and mouth wash in COVID-19 management: a prospective, randomized pilot clinical trial (povidone-iodine in COVID-19 management).
Alsaleh S; Alhussien A; Alyamani A; Alhussain F; Alhijji A; Binkhamis K; Khan A; Javer A; Alshahrani FS
BMC Infect Dis; 2024 Mar; 24(1):271. PubMed ID: 38429662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
